2,384,3014,041,172Current portion of long-term debt
23,52555,994Total current liabilities
4,442,8846,885,021Long-term debt-21,970Other liabilities2,030,9432,216,916Total liabilities
6,473,8279,123,907Commitments and contingenciesStockholders' equityPreferred stock, $.001 par value, 5,000,000 shares authorized; no shares issued or outstanding as of September 30, 2011 and 2010
--Common stock, $.001 par value, 35,000,000 shares authorized; 19,069,078 and 18,853,584 shares issued and outstanding as of September 30, 2011 and 2010, respectively
105,786,650104,351,093Retained earnings (deficit)
(67,201,345)(69,868,351)Total stockholders' equity
38,604,37534,501,595Total liabilities and stockholders' equity$
Gregory A. Gould
Interim President, Chief Executive Officer and Chief Financial Officer
SeraCare Life Sciences, Inc.
MacDougall Biomedical Communications
|SOURCE SeraCare Life Sciences, Inc.|
Copyright©2010 PR Newswire.
All rights reserved